Neurogastrx Bags $45M, a New CEO and a HQ Move to the Greater Boston Area Post author:Sam Post published:January 3, 2018 Post category:BioPharma The Series A financing was co-led by 5AM Ventures, OrbiMed Advisors and venBio Partners. Source: BioSpace You Might Also Like How Cambridge Biotech Akcea Teaches Its 80 Employees to Put a Human Face on Illnesses December 5, 2017 Immunovaccine Appoints Seasoned Financial Executive As CFO February 2, 2017 G1 Therapeutics Unveils Positive Mid-Stage Data for Myelopreservation in SCLC Patients March 4, 2018
How Cambridge Biotech Akcea Teaches Its 80 Employees to Put a Human Face on Illnesses December 5, 2017
